At ICPR 2024, we spoke with Ethan Nadelmann, founder of the Drug Policy Alliance, about how psychedelics fit into the broader landscape of drug policy reform.<\/p>\n\n\n\n\n\n\n\n
Ethan Nadelmann, JD, PhD, is a longtime ally and friend. He founded the Drug Policy Alliance in the United States and hosts the Psychoactive<\/em> podcast. In our conversation, we explored the psychedelic renaissance and the risks of backlash, the challenge of ensuring access beyond the wealthy, and what fair regulation of non-medical use could look like. We also discussed setbacks in Oregon and Vancouver, the continuing realities of the war on drugs in the U.S., and how the momentum around psychedelics could help drive broader drug policy reform.<\/p>\n\n\n\n Note: This interview was recorded prior to the FDA\u2019s decision to reject MDMA therapy for PTSD.<\/em><\/p>\n\n\n